Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries

Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries

Thumbnail Image
Download
Name

nihms926003.pdf

Description
Accepted version
Size

1.15 MB

Format

Adobe PDF

Checksum (MD5)

846c9e950a44fbc257cd6ae42ce019a0

sword-2019-09-13T18:40:24.original.xml (130 B)
Original SWORD entry document
Author(s)
Kelly, Ryan L
•
Le, Doris
•
Zhao, Jessie
•
Wittrup, K Dane
Date Issued
2018
Journal
Journal of Molecular Biology
Publisher
Elsevier BV
Version
Author's final manuscript
Abstract
© 2017 Elsevier Ltd Successful antibody development requires both functional binding and desirable biophysical characteristics. In the current study, we analyze the causes of one hurdle to clinical development, off-target reactivity, or nonspecificity. We used a high-throughput nonspecificity assay to isolate panels of nonspecific antibodies from two synthetic single-chain variable fragment libraries expressed on the surface of yeast, identifying both individual amino acids and motifs within the complementarity-determining regions which contribute to the phenotype. We find enrichment of glycine, valine, and arginine as both individual amino acids and as a part of motifs, and additionally enrichment of motifs containing tryptophan. Insertion of any of these motifs into the complementarity-determining region H3 of a “clean” antibody increased its nonspecificity, with greatest increases in antibodies containing Trp or Val motifs. We next applied these rules to the creation of a synthetic diversity library based on natural frameworks with significantly decreased incorporation of such motifs and demonstrated its ability to isolate binders to a wide panel of antigens. This work both provides a greater understanding of the drivers of nonspecificity and provides design rules to increase efficiency in the isolation of antibodies with drug-like properties.
MIT Department
Koch Institute for Integrative Cancer Research at MIT
Massachusetts Institute of Technology. Department of Chemical Engineering
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
http://creativecommons.org/licenses/by-nc-nd/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/134710
DOI of Published Version
https://doi.org/10.1016/J.JMB.2017.11.008
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.